1. UBS Lux Equity Fund Biotech USD
UBS Lux Equity Fund Biotech USD P-acc
Fee
2.25%
ISIN
LU0069152568
Holdings
10
World xFund Allocation A
Fee
1.33%
ISIN
SE0015949904
Holdings
25
We have information about 14 holdings in UBS Lux Equity Fund Biotech USD, where the largest holding is Regeneron Pharmaceuticals (10.04), followed by Vertex (9.9) and Moderna (9.21). In comparison with World xFund Allocation A, we have 30 holdings where Camurus is the largest holding (7.84), followed by Novo Nordisk (5.54) and Palo Alto Networks (3.89).
Here we compare the holdings in UBS Lux Equity Fund Biotech USD and World xFund Allocation A.
| UBS Lux Equity Fund Biotech USD | World xFund Allocation A |
|---|---|
|
10.04 % |
 7.84 % |
|
9.9 % |
 5.54 % |
|
9.21 % |
 3.89 % |
|
6.54 % |
3.45 % |
|
5.52 % |
3.36 % |
|
4.66 % |
2.97 % |
|
4.32 % |
2.85 % |
|
4.13 % |
2.81 % |
|
3.75 % |
2.52 % |
|
3.28 % |
2.5 % |
| - |
 2.48 % |
| - |
1.78 % |
| - |
1.52 % |
| - |
1.42 % |
| - |
1.41 % |
| - |
1.38 % |
| - |
1.38 % |
| - |
1.34 % |
| - |
1.26 % |
| - |
1.25 % |
| - |
1.24 % |
| - |
1.24 % |
| - |
 1.22 % |
| - |
1.22 % |
| - |
1.2 % |
The list of fund holdings was last updated on April 17, 2025.
